Bernat Olle, Ph.D.

Chief Executive Officer


Bernat Olle, Ph.D.

Chief Executive Officer

Dr. Olle is a co-founder and Chief Executive Officer of Vedanta Biosciences. He has been a member of the founding teams of several companies of the PureTech portfolio and served as a member of the Board of Directors of Vedanta Biosciences and Follica Biosciences.

In 2013 Dr. Olle was named "Innovator of the Year" in MIT Technology Review Spain's "Innovators under 35" awards. He completed his doctoral work at the Chemical Engineering Department at MIT, where he developed a novel method for large-scale bacterial culture. During his graduate work, Dr. Olle was awarded the "la Caixa" fellowship. Dr. Olle received his B.S. in Chemical Engineering from Universitat Rovira i Virgili, in the Republic of Catalonia, his M.S. and PhD. in Chemical Engineering Practice from MIT, and his M.B.A. from the MIT Sloan School of Management. He has published his work in journals including Nature and Nature Biotechnology.

Ending the War on Microbes | Bernat Olle | TEDxCambridge


Bruce Roberts, Ph.D.

Chief Scientific Officer


Bruce Roberts, Ph.D.

Chief Scientific Officer

Dr. Roberts has 30 years of experience in biotechnology and pharmaceutical drug discovery and development. He most recently served as Head of Neuro-Immunology and Immune-Mediated Disease Research at Sanofi Genzyme where he directed pre-clinical efforts resulting in the introduction of therapeutic antibodies, gene therapies, cell therapies and small molecules into multiple clinical trials for the treatment of cancer, multiple sclerosis and autoimmunity. He also directed research efforts in support of several approved products including lemtrada, aubagio, thymoglobulin, Mozobil, alemtuzumab, leukine, chlofarabine and fludarabine and contributed to the generation of ecallantide.

Dr. Roberts has authored more than 50 peer-reviewed publications and contributed to several issued patents and patent applications. He received his PhD. in Biochemistry from the University of Ottawa, Canada.


Dan Couto

Chief Operating Officer


Dan Couto

Chief Operating Officer

Mr. Couto has 25 years of experience in biotechnology, biologics drug development and cGMP manufacturing, including at Merck Sharp Dohme Biologics UK (formerly Avecia Biologics) where he served as Vice President of Commercial Manufacturing Operations and was responsible for late stage and commercial manufacturing operations. In addition, Mr. Couto has held senior positions with several biotech companies including Nuvelo, Genzyme Transgenics and Advanced Biosystems and, most recently, was Senior Vice President of Manufacturing and Facilities Operations at ContraFect Corporation where he was responsible for chemistry & manufacturing controls, supply chain, quality assurance and facilities.

Mr. Couto holds multiple U.S. patents. He received his B.S. in Chemical Engineering from Rensselaer Polytechnic Institute.


Debra Winslow

VP Program Management & Operations Planning


Debra Winslow

VP Program Management & Operations Planning

Deb Winslow has joined Vedanta after working in the biotech industry for over 25 years in various roles from early product development through commercialization.  She received a BS in biochemistry from UNH, an MBA from Bentley University, is a Regulatory Affairs Certified (RAC) professional and a Project Management Professional (PMP).  Her roles is to set up program management and operational planning systems to ensure successful program execution across the company.


Dmitri Bobilev

VP, Head of Clinical Development


Dmitri Bobilev

VP, Head of Clinical Development

Dr. Bobilev is the VP, Head of Clinical Development at Vedanta. He is responsible for leading Vedanta’s clinical development efforts and advancing clinical testing across a range of indications, including C. difficile, cancer, and autoimmune conditions.

Prior to joining Vedanta, Dr. Bobilev served as Executive Director of Immuno-Oncology at Tesaro, where he played a key role in defining the early clinical development strategies for Tesaro’s immuno-oncology portfolio and for combination studies with niraparib (Zejula). He designed and implemented development plans for novel immune checkpoint inhibitors in multiple oncology indications. Prior to Tesaro, Dr. Bobilev served as Medical Director at Sanofi and contributed to the successful development of cabazitaxel (Jevtana).

Dr. Bobilev received his Medical Degree from Omsk Medical Institute in Russia and completed his training in Medical and Radiation Oncology at the Soroka Medical Center at Ben-Gurion University of the Negev, Israel. He held a fellowship in Oncology Drug Development at Pfizer Global Research and Development. He is board certified in medical oncology and radiation therapy.


Erik Spek, Ph.D., J.D.

SVP, Head of Legal Affairs and IP


Erik Spek, Ph.D., J.D.

SVP, Head of Legal Affairs and IP

Erik Spek is the head of Intellectual Property at Vedanta. Prior to his current position, Erik was Director of IP at Epizyme and worked at Boston-based IP law firm Wolf Greenfield. Erik graduated cum laude from Suffolk Law School in Boston. He earned his B.S. in Chemistry and Philosophy from Vrije Universiteit in Amsterdam and his PhD. in Biophysical Chemistry from New York University.


Kevin Coveney

SVP Finance


Kevin Coveney

SVP Finance

Mr. Coveney is a CPA and former audit partner with over 25 years of public accounting and private company experience.  He specializes in working with start-up companies from inception up through and post a public offering in the biotechnology, medical device and technology industries. 

Well versed in balance sheet, cash management, risk management, and Sarbanes Oxley compliance as well as treasury and tax matters including planning and compliance, contract negotiations, financial planning and analysis, regulatory matters, lease negotiations, human resource, benefits including salary & equity negotiations and compensation planning.

He was most recently the Senior Vice President of Finance & FP&A at Berg LLC as well as the interim CFO for a period of two years.


Adam Curet

Laboratory Manager


Adam Tomich

Sr. Research Associate, Microbiology


Adrian Douglas

Maintenance Technician


Alex Buckley

Supply Chain Supervisor


Alicia Szretter

Manager, Manufacturing


Amanda Prince

Scientist, Immunology


Antonio Volpini

Research Associate, Platform


Brian Klein, Ph.D.

Staff Scientist II


Cintia Felix

Principal Research Associate


Colin Heberling

Senior Research Associate Bioinformatics


Dan Clarici

Process Engineer


Dave Crane

Sr. Manager, Quality Assurance


Diana Wiesnoski

Sr. Research Associate, Molecular Bio & Sequencing


Diti Goradia

Sr. QA Associate


Elon Elzam

Manager, Manufacturing


Evan Kustubardis

Senior QA Compliance Specialist


Gouri Vadali

Principle Research Associate, Systems Biology


Jack Kyte

Sr. Director, Human Resources


Jared Hendrickson

Research Associate, Bioinformatics


Jason Norman, Ph.D.

Associate Director, Systems Biology


Jil Ulrich

Associate Director, CMC Operations


Kathryn Dudley

EA & Executive Administrator


Kelsey Brown

Clinical Research Associate


Ketaki Nade

Analytical Development


Kris Ireland

Director of Manufacturing


Lorraine Hughes

Sr Director, Clinical Operations


Maggie McGuigan

Assistant Controller


Maria Kim

Clinical Research Associate


Melissa Dsouza

Scientist II, Clinical Bioinformatics


Mollie Murnane

Sr. Research Associate, Microbiology - Platform


Rajita Menon

Scientist, Bioinformatics


Robert D’Orazio

Senior Manufacturing Associate


Rohan Chengappa

SAP Specialist


Rose Szabady, Ph.D.

Associate Director, Immunology


Rowan Pereira

Receptionist/Office Coordinator


Ryan Busha

Senior Clinical Research Manager


Scott Michonski

Manager of Process Development & Technical Operations, Upstream


Shilpa Reddy

Scientist I


Silvia Caballero, Ph.D.

Scientist II


Steve Derby

Senior Manufacturing Associate